Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6Lymphoid 5Tumor-Agnostic 4Breast 4Head & Neck 3Thoracic 2Plasma cell 2Other 2Genitourinary 2Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1Endocrine 1

Conditions

Oral Complications 1

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Glutamine × Other solid neoplasm × Clear all
NCT00003898 2011-03-01

Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation

Roswell Park Cancer Institute

Phase 2 Completed
120 enrolled
Other solid neoplasm

Oral Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡